EN DE
STOCK COMPARISON

Star Sports Medicine Co. vs Abbott Laboratories: Fair Value & Quality

Both stocks run through our valuation models. Here is how Star Sports Medicine Co. (1609) and Abbott Laboratories (ABT) compare, as of Sep 10, 2026.

As of Sep 10, 2026, Fair Value Calculator sees Abbott Laboratories as the less overvalued of the two: Star Sports Medicine Co. trades at HK$113 versus a fair value of HK$51.39 (-54%), while Abbott Laboratories trades at $105 versus $74.79 (-29%).
Star Sports Medicine Co.
1609.HK · HKD · Industrials
-54%
upside to fair value
overvalued
PriceHK$113
Fair ValueHK$51.39
Quality74/100
Abbott Laboratories
ABT · USD · Health Care
-29%
upside to fair value
overvalued
Price$105
Fair Value$74.79
Quality67/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Star Sports Medicine Co.Abbott Laboratories
Valuation
53.8×P/E (TTM)27.7×
21.10×P/S (TTM)3.89×
13.95×P/B3.36×
58.6×EV/EBITDA15.1×
—PEG1.47×
−54.4%Fair value upside−28.9%
—Dividend yield2.3%
—Dividend per share$2.44
Profitability
8%Operating margin13%
1.71×EBIT margin trend (5Y)1.19×
25%Return on equity12%
12%Return on assets6%
Growth
0%Revenue growth (YoY)8%
40.1%Avg. growth/yr (3Y)0.5%
—Avg. growth/yr (5Y)5.1%
+41.1%Value creation/yr+10.5%
Balance & size
476.7×Interest coverage (EBIT/interest)23.6×
0.03×Debt / equity0.19×
$1BMarket cap$175B
healthyGrowth qualityhealthy
Valuation multiples (P/E, P/S, P/B, EV/EBITDA) are shown but not scored here: the two companies sit in different sectors, and multiples only compare fairly between similar business models. PEG stays scored, as it relates the P/E to growth.

Star Sports Medicine Co. leads: 6 to 2 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Star Sports Medicine Co.of which business quality 75 · market factors 0 Abbott Laboratoriesof which business quality 66 · market factors 50
ProfitabilityMargins and returns on capital today
76
50
Quality GrowthAre margins and returns improving?
78
47
CashflowEarnings quality: real cash, not paper profit
79
71
Fin. StrengthBalance sheet, leverage, solvency risk
90
80
InvestmentDisciplined investing over empire-building
21
65
Low VolatilityCalm price path (market factor)
0
83
MomentumPrice trend over the last 3–12 months (market factor)
0
40
52W MomentumDistance to the 52-week high (market factor)
0
29
Net IssuanceBuybacks instead of dilution
82
84

What the models say

How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.

above the price, more than 15% above close to the price, 85% to 115% of the price below the price, more than 15% below

Model familyStar Sports Medicine Co.Price HK$113Abbott LaboratoriesPrice $105
DCF Models-41%below the priceHK$66.74-31%below the price$73.01
Earnings-Based-33%below the priceHK$75.94-72%below the price$29.42
Dividend Discountn/a-62%below the price$39.73
Multiples-62%below the priceHK$43.27-33%below the price$70.72
Asset-Based-93%below the priceHK$7.45-81%below the price$20.05
Growth DCF-57%below the priceHK$49.01-36%below the price$67.02
Economic Profit-69%below the priceHK$34.58-64%below the price$37.49
Growth Earnings-9%close to the priceHK$102-33%below the price$70.25
Minimum-93%below the priceHK$7.45-81%below the price$20.05
Maximum-9%close to the priceHK$102-31%below the price$73.01
Median-57%below the priceHK$49.01-49%below the price$53.37
Geometric mean-62%below the priceHK$43.24-56%below the price$46.36

Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.

Star Sports Medicine Co.: 23 of 24 models see the stock below the current price.

Abbott Laboratories: 26 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Star Sports Medicine Co.
Bear HK$39.06Fair Value HK$51.39Bull HK$63.71
HK$113 = current price (white tick)
Abbott Laboratories
Bear $51.13Fair Value $74.79Bull $94.43
$105 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Star Sports Medicine Co. · Industrials

Quality score74 · Top 25%
Fair value upside-54% · below median

Abbott Laboratories · Health Care

Quality score67 · Top 25%
Fair value upside-29% · above median

Bottom line

As of Sep 10, 2026, Fair Value Calculator sees Abbott Laboratories as the less overvalued of the two: Star Sports Medicine Co. trades at HK$113 versus a fair value of HK$51.39 (-54%), while Abbott Laboratories trades at $105 versus $74.79 (-29%).

Star Sports Medicine Co. has the higher quality score (74/100).

See the full analysis →
Star Sports Medicine Co. · Abbott Laboratories

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Star Sports Medicine Co.

Alphabet Inc Class C vs Verizon CommunicationsAlphabet Inc Class C vs At&tAlphabet Inc Class C vs NetEaseAmazon.com vs Alibaba Group Holding

Related to Abbott Laboratories

Abbott Laboratories vs UnitedHealth GroupEli Lilly and vs UnitedHealth GroupJohnson & Johnson vs UnitedHealth GroupAbbVie vs UnitedHealth Group
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.